DeepMed Research

Georgetown University

🇬🇹Guatemala

Country: 🇬🇹Guatemala

Ownership: Private

Established: 1789-01-23

Employees: 5K

Market Cap: -

Website: http://www.georgetown.edu

Clinical Trials

Exertional Exhaustion in Chronic Fatigue Syndrome

Not Applicable

Completed

Conditions: Chronic Fatigue Syndrome

Interventions: Procedure: Submaximal bicycle exercise stress test on Days 1 and 2

First Posted Date: 2018-06-26

Last Posted Date: 2019-06-20

Lead Sponsor: Georgetown University

Target Recruit Count: 72

Registration Number: NCT03567811

START & STOPP in GWI

Completed

Conditions: Gulf War Syndrome

Interventions: Other: 2 submaximal exercise stress tests

First Posted Date: 2018-06-18

Last Posted Date: 2019-06-20

Lead Sponsor: Georgetown University

Target Recruit Count: 52

Registration Number: NCT03560830

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States

Genetic Education in BRCA Families

Not Applicable

Conditions: BRCA1 Mutation
BRCA2 Mutation

Interventions: Behavioral: Web + Streamlined Telephone Genetic Information

First Posted Date: 2018-06-04

Last Posted Date: 2024-08-27

Lead Sponsor: Georgetown University

Target Recruit Count: 240

Registration Number: NCT03544983

Locations: 🇺🇸
Georgetown University Medical Center/Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States
🇺🇸
George Washington University, Washington, District of Columbia, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

and more 1 locations

Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery

Phase 2

Terminated

Conditions: DCIS

Interventions: Drug: Palbociclib

First Posted Date: 2018-05-24

Last Posted Date: 2024-01-18

Lead Sponsor: Georgetown University

Target Recruit Count: 17

Registration Number: NCT03535506

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸
Medstar Washington Hospital Center, Washington, District of Columbia, United States

Treatments for Anxiety: Meditation and Escitalopram

Phase 4

Completed

Conditions: Anxiety Disorders
Generalized Anxiety Disorder
Panic Disorder
Social Anxiety Disorder
Agoraphobia

Interventions: Other: Mindfulness-Based Stress Reduction
Drug: Escitalopram

First Posted Date: 2018-05-11

Last Posted Date: 2022-01-11

Lead Sponsor: Georgetown University

Target Recruit Count: 276

Registration Number: NCT03522844

Locations: 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States
🇺🇸
New York University, New York, New York, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment

Not Applicable

Completed

Conditions: Hereditary Breast and Ovarian Cancer

Interventions: Behavioral: BRCA-Gist

First Posted Date: 2018-04-30

Last Posted Date: 2022-04-25

Lead Sponsor: Georgetown University

Target Recruit Count: 95

Registration Number: NCT03511690

Locations: 🇺🇸
Capital Breast Care Center, Washington, District of Columbia, United States
🇺🇸
Georgetown University, Washington, District of Columbia, United States
🇺🇸
Nueva Vida, Alexandria, Virginia, United States

and more 1 locations

Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo

Phase 2

Conditions: Breast Cancer
Mastectomy

Interventions: Drug: Liposomal bupivacaine
Other: Placebo
Drug: Standard bupivacaine

First Posted Date: 2018-04-20

Last Posted Date: 2020-07-27

Lead Sponsor: Georgetown University

Target Recruit Count: 100

Registration Number: NCT03504865

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States

OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease

Phase 2

Completed

Conditions: Triple Negative Breast Cancer

Interventions: Drug: Capecitabine
Drug: Nivolumab

First Posted Date: 2018-04-04

Last Posted Date: 2024-12-03

Lead Sponsor: Georgetown University

Target Recruit Count: 45

Registration Number: NCT03487666

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸
MedStar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States

and more 1 locations

A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL

Phase 2

Active, not recruiting

Conditions: Chronic Lymphocytic Leukemia

Interventions: Drug: Venetoclax
Drug: Rituximab
Drug: Rituximab/Hyaluronidase Human

First Posted Date: 2018-03-16

Last Posted Date: 2025-02-06

Lead Sponsor: Georgetown University

Target Recruit Count: 25

Registration Number: NCT03467867

Locations: 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States
🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States

Older Breast Cancer Patients: Risk for Cognitive Decline

Recruiting

Conditions: Age-related Cognitive Decline
Cancer, Breast
Cognitive Decline

First Posted Date: 2018-03-01

Last Posted Date: 2025-03-11

Lead Sponsor: Georgetown University

Target Recruit Count: 1700

Registration Number: NCT03451383

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy